Actithera is a radiopharmaceutical biotech company translating medicinal chemistry insights into next-generation radioligand therapies (RLTs). Founded in 2021 by drug discovery innovator Dr. Andreas Goutopoulos, and seed investors M Ventures, and Arkin Bio Ventures II, Actithera applies various molecular design strategies, including covalent-targeting and an isotope-agnostic philosophy to invent RLTs with significant differentiation and larger therapeutic windows. Headquartered in Oslo, Norway, and Cambridge, Massachusetts, Actithera is committed to advancing a differentiated pipeline addressing critical unmet needs in oncology.
| Website | https://actithera.com/ |
| Employees | 33 (11 on RocketReach) |
| Address | 1 Broadway 14th Floor, Cambridge, Massachusetts 02142, US |
| Phone | +1 617-780-8045 |
| Industry | Biotechnology Research |
Looking for a particular Actithera employee's phone or email?
Actithera Questions
Andreas Goutopoulos is the Founder and President, R and D of Actithera.
11 people are employed at Actithera.
Actithera is based in Cambridge, Massachusetts.
Top Actithera Employees
-
45+
-
Igor Mochalkin
VP, Discovery Technology at Actithera
Cambridge, MA, US24 -
Darshan Dalal
Chief Medical Officer at Actithera
New York, NY, US21 -
Hyelim Cho
VP, Head of Strategy at Actithera
Boston, MA, US1 -
44
-
Jing Zhao
Senior Medical Director, Global Clinical Development at Actithera
Baden-Württemberg, Germany2 -
Sarah Vanrenterghem
Head of Quality at Actithera
Wielsbeke, BE2
Related Companies
